Loading...
FRESENIUS KABI MALAYSIA SDN BHD — Docetaxel Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #15 buyer for Docetaxel · $550.9K import value · 22 shipments · MALAYSIA · DGFT Verified
FRESENIUS KABI MALAYSIA SDN BHD is the #15 importer of Docetaxel from India with $550.9K in import value and 22 verified shipments. FRESENIUS KABI MALAYSIA SDN BHD holds a 1.3% market share in Docetaxel imports based in MALAYSIA. The company sources from 1 verified supplier across 21 formulations shipped to 1 country. Overall, FRESENIUS KABI MALAYSIA SDN BHD imports 8 pharmaceutical products worth $3.5M across 2 therapeutic categories.
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $550.9K | 22 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD sources Docetaxel from 1 verified Indian supplier based on 22 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | VE PHARMA INC | PHILIPPINES | $598.9K | 57 | $10.5K |
| 14 | VE PHARMA INC. | PHILIPPINES | $543.2K | 24 | $22.6K |
| 15 | FRESENIUS KABI MALAYSIA SDN BHD ★ | MALAYSIA | $524.4K | 18 | $29.1K |
| 4 | PFIZER SERVICE COMPANY BV | UNITED STATES | $500.0K | 10 | $50.0K |
| 11 | FRESENIUS KABI CHILE LTDA. | CHILE | $500.0K | 10 | $50.0K |
FRESENIUS KABI MALAYSIA SDN BHD ranks #15 among 641 Docetaxel importers from India. Average shipment value of $29.1K compared to the market average of $19.4K. The closest competitors by value are VE PHARMA INC and VE PHARMA INC..
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $550.9K | 22 | 100.0% |
FRESENIUS KABI MALAYSIA SDN BHD imports Docetaxel to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $550.9K.
| Formulation | Value | Shipments |
|---|---|---|
| DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL | $100.0K | 2 |
| DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL B | $50.0K | 1 |
| DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL BATCH NO. 87240021AA MFG. DT. 01/2024 EXP. DT. 12/2025NOS | $50.0K | 1 |
| DAXOTEL(DOCETAXEL)INJ.80MG/4ML VIALB NO-87240085AA MFG.02/24EXP.01/2026 | $50.0K | 1 |
| DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL(BATCH NO. 87250102AA, 87250103AC MFG. DT. 03/2025, EXP. DT. 02/2027) | $50.0K | 1 |
| DAXOTEL (DOCETAXEL) INJ.80MG/4ML VIAL | $46.4K | 1 |
| DAXOTEL DOCETAXEL INJ. 80MG/4ML VIAL BATCH NO. 87230427BB MANUFACTURING . DT. 09/2023 EXP. DT. 08/2025 | $40.4K | 1 |
| DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL BATCH NO. 87240023BB MFG. DT. 01/2024 EXP. DT. 12/2025NOS | $39.3K |
India exported $12.4M worth of Docetaxel through 2,634 shipments from 253 suppliers to 120 countries, serving 641 buyers globally. FRESENIUS KABI MALAYSIA SDN BHD imports $550.9K of this total, accounting for 1.3% of India's Docetaxel exports with 22 shipments from MALAYSIA. This is verified from 22 customs shipment records covering 21 distinct formulations.
FRESENIUS KABI MALAYSIA SDN BHD's average Docetaxel order value is $25.0K per consignment, based on 22 shipments totaling $550.9K. FRESENIUS KABI MALAYSIA SDN BHD is based in MALAYSIA and ranks #15 among all Docetaxel importers from India by value. The company sources from 1 verified supplier in India.
FRESENIUS KABI MALAYSIA SDN BHD sources Docetaxel from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($550.9K, 100.0%). This is based on 22 customs records.
FRESENIUS KABI MALAYSIA SDN BHD ranks #15 among 641 Docetaxel importers from India with a 1.3% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($3.3M), FRESENIUS KABI DEUTSCHLAND GMBH ($2.5M), FRESENIUS KABI COLOMBIA SAS ($1.1M). FRESENIUS KABI MALAYSIA SDN BHD processed 22 shipments from MALAYSIA.
FRESENIUS KABI MALAYSIA SDN BHD also imports these oncology products. Each links to the detailed product page.
FRESENIUS KABI MALAYSIA SDN BHD imports 8 products worth $3.5M. Beyond Docetaxel, top products include Carboplatin, Oxaliplatin, Epirubicin, Gemcitabine, Cytarabine. View the complete FRESENIUS KABI MALAYSIA SDN BHD profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Docetaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI MALAYSIA SDN BHD's Docetaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI MALAYSIA SDN BHD
Full Company Profile →
8 products · $3.5M total trade · 2 categories
| 1 |
| DAXOTELDOCETAXELINJ.80MG/4ML VIALB NO-87230402BC MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 | $24.1K | 1 |
| DAXOTEL DOCETAXEL INJECTION 80MG 4ML VIAL BATCH NO 87230066BA MFG DT 02 2023 EXP DT 01 2025 | $23.5K | 1 |
FRESENIUS KABI MALAYSIA SDN BHD imports 21 distinct Docetaxel formulations from India. The top formulation is DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL with 2 shipments worth $100.0K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 641+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI MALAYSIA SDN BHD.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Docetaxel. For current order-level data, contact TransData Nexus.